Vetera Gold XP + VEE

Vetera Gold XP+VEE
Single dose - 1 dose syringe
Single dose-Box - 1 dose syringe - Box of 10
10 Dose Vial - Special Order, please allow an extra day for delivery
SKU : 2215
Price: $72.89
Price: $72.89

Influenza, Herpesvirus types 1 and 4, West Nile Virus, Venezuelan, Eastern and Western Equine Encephalomyelitis, and Tetanus

  • More flexibility with 8-way
  • Provides protection against as many as 8 diseases in 1 convenient vaccine
  • Reduces the number of injections needed
  • Allows customization of vaccination protocols to meet individual needs of horses

We will ship all cooler items Next Day Air. No refunds/guarantees will be honored for orders with Express Delivery chosen.

*Manufacturer restricts additional discounts on this item unless explicitly specified

Description

New Vetera® XP Vaccines provide protection against Richmond/07, Ohio/03, and Kentucky/95 viruses, meeting international and US guidelines for equine flu protection.

Contains

    • Equine influenza virus
    • Equine herpesvirus type 1
    • Equine herpesvirus type 4
    • West Nile virus
    • Eastern equine encephalomyelitis
    • Western equine encephalomyelitis
    • Tetanus
    • Venezuelan equine encephalomyelitis


by Boehringer Ingelheim

    All Vaccines Now Ship OVERNIGHT Delivery Only at a great LOW Rate!
    Vaccines are shipped in a cooling package.

    Click here for our Vaccine Shipping Schedule.

    VETERA® GOLD + VEE

    Boehringer Ingelheim

    Encephalomyelitis-Rhinopneumonitis-Influenza-West Nile Virus Vaccine,

    Eastern & Western & Venezuelan, Killed Virus

    Tetanus Toxoid

    Indications: For vaccination of healthy horses 4 months of age or older as an aid in the prevention of disease caused by Eastern, Western, and Venezuelan Encephalomyelitis, and tetanus; as an aid in the prevention of viremia and mortality, and an aid in the reduction of severity of clinical disease caused by West Nile Virus; as an aid in the reduction of respiratory disease caused by Equine Herpesvirus types 1 and 4 (EHV-1 and EHV-4), and Equine Influenza virus types A2 North American and A2 Eurasian. The duration of immunity against Equine Influenza is at least 6 months, and against West Nile Virus is at least 12 months.

    Administration and Dosage: Shake well before use. Using aseptic technique, inoculate horses intramuscularly with a 1 mL dose. Administer a second 1 mL dose intramuscularly in 3-4 weeks using a different injection site. Revaccinate annually and prior to anticipated exposure

    with a single 1 mL intramuscular dose.

    Precautions: Store at 35-45°F (2-7°C. Protect from freezing. Do not vaccinate within 21 days before slaughter. Use entire contents when first opened. Anaphylactoid reactions may occur following use. Antidote: Epinephrine.

    This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies, or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions.

    Preservatives: Gentamicin and Amphotericin B.

    For Veterinary Use Only

    Boehringer Ingelheim Vetmedica, Inc., St. Joseph, MO 64506

    U.S. Veterinary License No. 124

     

    Code

     

    1 Dose/1 mL

     

     

    10 Doses/10 mL

    136-125

    36104-00, 36103-00

    NAC No.: 10282690

    Loading...